<?xml version="1.0" encoding="UTF-8"?>
<ref id="pntd.0007964.ref046">
 <label>46</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>McCarthy</surname>
   <given-names>MW</given-names>
  </name>, 
  <name>
   <surname>Walsh</surname>
   <given-names>TJ</given-names>
  </name>. 
  <article-title>Drug development challenges and strategies to address emerging and resistant fungal pathogens</article-title>. 
  <source>Expert Rev Anti Infect Ther</source>. 
  <year>2017</year>;
  <volume>15</volume>: 
  <fpage>577</fpage>â€“
  <lpage>584</lpage>. 
  <pub-id pub-id-type="doi">10.1080/14787210.2017.1328279</pub-id>
  <?supplied-pmid 28480775?>
  <pub-id pub-id-type="pmid">28480775</pub-id>
 </mixed-citation>
</ref>
